Abstract:Egypt is the third most densely inhabited African country. Due to the economic burden and healthcare costs of overpopulation, genomic and genetic testing is a huge challenge. However, in the era of precision medicine, Egypt is taking a shift in approach from "one-size-fits all" to more personalized healthcare via advancing the practice of medical genetics and genomics across the country. This shift necessitates concrete knowledge of the Egyptian genome and related diseases to direct effective preventive, diagnostic and counseling services of prevalent genetic diseases in Egypt. Understanding disease molecular mechanisms will enhance the capacity for personalized interventions. From this perspective, we highlight research efforts and available services for rare genetic diseases, communicable diseases including the coronavirus 2019 disease (COVID19), and cancer. The current state of genetic services in Egypt including availability and access to genetic services is described. Drivers for applying genomics in Egypt are illustrated with a SWOT analysis of the current genetic/genomic services. Barriers to genetic service development in Egypt, whether economic, geographic, cultural or educational are discussed as well. The sensitive topic of communicating genomic results and its ethical considerations is also tackled. To understand disease pathogenesis, much can be gained through the advancement and integration of genomic technologies via clinical applications and research efforts in Egypt. Three main pillars of multidisciplinary collaboration for advancing genomics in Egypt are envisaged: resources, infrastructure and training. Finally, we highlight the recent national plan to establish a genome center that will aim to prepare a map of the Egyptian human genome to discover and accurately determine the genetic characteristics of various diseases. The Reference Genome Project for Egyptians and Ancient Egyptians will initialize a new genomics era in Egypt. We propose a multidisciplinary governance system in Egypt to support genomic medicine research efforts and integrate into the healthcare system whilst ensuring ethical conduct of data.

The Egypt Genome Project

Egypt Genome: Towards an African new genomic era

Genomics in Egypt: Current Status and Future Aspects

Ancient Egyptian Mummy Genomes Suggest an Increase of Sub-Saharan African Ancestry in Post-Roman Periods

First insights into the metagenome of Egyptian mummies using next-generation sequencing

Mitochondrial DNA sequence diversity in a sedentary population from Egypt

Recommendations for genetic variation data capture in developing countries to ensure a comprehensive worldwide data collection

Genome Tunisia Project: paving the way for precision medicine in North Africa

Unique Features of Germline Variation in Five Egyptian Familial Breast Cancer Families Revealed by Exome Sequencing

Human Variome Project Country Nodes: Documenting Genetic Information Within a Country

Clinical and Genetic Spectrum of Patients With Mitochondrial Disease in a Pediatric Egyptian Cohort: Novel Variants and Phenotypic Expansion

The sequencing and interpretation of the genome obtained from a Serbian individual

High-coverage nanopore sequencing of samples from the 1000 Genomes Project to build a comprehensive catalog of human genetic variation

Nanopore sequencing of 1000 Genomes Project samples to build a comprehensive catalog of human genetic variation

The clinical and genetic landscape of developmental and epileptic encephalopathies in Egyptian children

A draft Arab pangenome reference

High throughput human genotyping for variants associated with malarial disease outcomes using custom targeted amplicon sequencing

A Comprehensive Analysis of 3 Moroccan Genomes Revealed Contributions From Both African and European Ancestries

Uganda genome resource enables insights into population history and genomic discovery in Africa

Capturing All Disease-Causing Mutations for Clinical and Research Use: Toward an Effortless System for the Human Variome Project

Customized targeted massively parallel sequencing enables the identification of novel pathogenic variants in Tunisian patients with developmental and epileptic encephalopathy